Company intelligence / Profile preview

INNOTHERA

Chouzy-sur-Cisse, Centre, Franceinnothera.fr ↗
Ownership
Private
Employees
~1200
Development stage
Other
01

Overview

INNOTHERA markets pharmaceuticals and medical devices for everyday pathologies such as venous insufficiency and metabolic imbalances. The company has a global commercial presence but does not publicly disclose clinical trial results or investigational programs.

Therapeutic areas
Infectious DiseasesWomen's HealthMetabolic DisordersCardiovascular
Modalities
Small molecule (pharmaceuticals for common illnesses and mineral-calcium imbalances)Medical device (elastic vein compression, orthopedics, podiatry products)Textile-based medical devices ("dedicated medical textiles")Device ("smart health" products)
Industry
Biotech
02

Drug pipeline

3 assets

IDEOS

4

2 more assets in the full pipeline.

Beyond the preview

Go deeper on INNOTHERA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on INNOTHERA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call